In a world chasing headlines and hype, it’s easy to forget that consistency still counts. When well-run, boring businesses ...

Clarity, along with most Aussie biotech, has been caught in a double whirlwind: a sharp sell-off in US healthcare stocks and ...

Markets might have needed a break last week—but this week, they roared back to life. Call it the Trump whiplash effect.

A study of 53,402 employees at the Cleveland Clinic found those who received the 2024-2025 flu vaccine were 27% more likely ...

The 'perfect investor' sells the exact top and buys the exact bottom of every market cycle, but you could still outperform ...

Property can build wealth but it’s no free ride. If you’re not ready for rate hikes, repairs, and long holding periods, think ...

Forecasts for more cash rate cuts by the RBA in 2025 have stoked demand for gold, as lines regularly form outside a Martin ...

After the whiplash markets have given everyone in the past few weeks, our experts thought an extra bonus from the Easter ...

This year the Hang Seng Index has soared, beating the US markets and its global peers. Chinese companies delivered strong ...

Money is made by buying great companies at attractive prices. Such opportunities only come along during periods of heightened ...

Phil King discusses the Opthea fiasco, his current outlook and whether we’ve seen the bottom in equity markets.

That kind of revenue growth makes the financial results from 100-baggers like Afterpay ( ASX: APT) and Pro Medicus ( ASX: PME ...